By comparing the gene expression of these tumors, we explored biomarkers for predicting the castration resistance of prostate cancer and found that the α2 chain of interleukin‐13 receptor (IL13Rα2) was highly expressed in castration‐resistant models. Here, IL13RA2 is linked to prostate cancer.